Normobucal (Benzocaine)

Benzocaine, the active ingredient in Normobucal, is a local anesthetic presented as a topical formulation for oromucosal use. It provides temporary relief of oral mucosal pain, sore mouth, teething discomfort and minor oral lesions in children and adults. It is formulated for easy application to the affected area and is available without a prescription in the European market.

GNH USA supplies Normobucal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with established distribution networks across Europe, Asia and the Americas.

Normobucal, a benzocaine‑based topical anesthetic, works locally on the oral mucosa to quickly relieve pain and discomfort associated with common mouth conditions.

Oral mucosal pain: provides temporary numbing of painful lesions in the mouth. Sore mouth: reduces discomfort from inflammation or irritation of the oral lining. Teething discomfort: eases gum pain associated with infant tooth eruption. Minor oral lesions: alleviates pain from aphthous ulcers or small injuries.

Benzocaine may cause local or systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Mild burning sensation at the application site. - Localized redness or mild irritation. - Temporary numbness extending slightly beyond the treated area. - Mild itching. - Altered taste perception. - Slight swelling of the mucosa.

Serious or Rare Side Effects: - Methemoglobinemia, a blood disorder reducing oxygen delivery. - Severe allergic reaction, including anaphylaxis. - Persistent numbness lasting longer than expected. - Tissue necrosis with excessive or prolonged use. - Respiratory distress. - Cardiovascular collapse.

When using Normobucal, consider the following precautions to minimise risk and ensure effective relief.

Allergy assessment: verify patient has no known hypersensitivity to benzocaine or related compounds. Application limit: apply only a thin layer to the affected area and avoid excessive use. Duration of use: limit treatment to short‑term periods, typically not exceeding 7 days without medical review. Age restriction: avoid use in infants under 2 years unless directed by a healthcare professional. Avoid broken skin: do not apply on extensive mucosal lesions or open wounds. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Benzocaine can interact with certain substances, altering its safety profile.

Major Interactions (Avoid): - Oxidizing agents: concurrent use with nitrites, sulfonamides or phenylhydrazine may increase risk of methemoglobinemia. - Other topical anesthetics: combined application can lead to excessive numbness and systemic toxicity. - Alcohol‑based mouthwashes: may enhance absorption and irritation.

Moderate Interactions (Monitor Closely): - Anticoagulants: caution as mucosal irritation could increase bleeding risk. - MAO inhibitors: monitor for potential hypotensive effects when combined with vasodilatory agents. - Systemic nitrates: observe for additive vasodilatory response.